Harrow Inc (HROW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HROW | OCUL | SPRY | ||
| Company | Harrow Inc | Ocular Therapeut | Ars Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 40.06 | 9.17 | 14.01 | ||
| High | 40.06 | 9.20 | 14.37 | ||
| Low | 37.00 | 8.62 | 13.58 | ||
| Last | 37.97 | 8.69 | 13.78 | ||
| Change | -1.04 | -0.47 | -0.23 | ||
| % Change | -2.67% | -5.13% | -1.64% | ||
| Volume | 1,102,500 | 1,383,700 | 1,057,300 | ||
| 20-Day Average Volume | 720,355 | 926,380 | 1,293,485 | ||
| Previous Close | 39.01 | 9.16 | 14.01 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 47.98 | 10.62 | 15.35 | ||
| 20-Day Raw Stochastic | 4.68% | 2.22% | 8.16% | ||
| 20-Day Relative Strength | 36.91% | 37.68% | 44.56% | ||
| Weighted Alpha | +168.79 | +149.25 | +140.57 | ||
| Today's Opinion | 40% Buy | 40% Buy | 64% Buy | ||
| Previous Opinion | 56% Buy | 56% Buy | 64% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -27.01% since 11/11/24 | -20.71% since 11/11/24 | -21.21% since 11/11/24 | ||
| Low | 37.00 on 11/18/24 | 8.62 on 11/18/24 | 13.36 on 11/15/24 | ||
| High | 54.19 on 11/13/24 | 11.12 on 11/13/24 | 17.90 on 11/12/24 | ||
| 1-Month | |||||
| %Chg | -33.94% since 10/18/24 | -23.30% since 10/18/24 | -13.82% since 10/18/24 | ||
| Low | 37.00 on 11/18/24 | 8.62 on 11/18/24 | 13.36 on 11/15/24 | ||
| High | 57.72 on 10/22/24 | 11.77 on 10/28/24 | 18.51 on 11/11/24 | ||
| 3-Month | |||||
| %Chg | -2.44% since 08/16/24 | +7.15% since 08/16/24 | +3.38% since 08/16/24 | ||
| Low | 37.00 on 11/18/24 | 8.11 on 08/19/24 | 11.00 on 09/06/24 | ||
| High | 59.23 on 10/18/24 | 11.77 on 10/28/24 | 18.51 on 11/11/24 | ||
| 6-Month | |||||
| %Chg | +126.55% since 05/17/24 | +40.84% since 05/17/24 | +52.60% since 05/17/24 | ||
| Low | 15.97 on 05/22/24 | 4.79 on 06/10/24 | 7.55 on 06/25/24 | ||
| High | 59.23 on 10/18/24 | 11.77 on 10/28/24 | 18.51 on 11/11/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,384,192 | 1,428,246 | 1,361,562 | ||
| Shares Outstanding, K | 35,483 | 155,922 | 97,185 | ||
| Annual Sales | 130,190,000 | 58,440,000 | 30,000 | ||
| Annual Net Income | -24,410,000 | -80,740,000 | -54,370,000 | ||
| Last Quarter Sales | 48,940,000 | 16,440,000 | 500,000 | ||
| Last Quarter Net Income | -6,470,000 | -43,780,000 | -12,520,000 | ||
| 60-Month Beta | 0.76 | 1.26 | 0.90 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.12 on 11/13/24 | -0.22 on 11/14/24 | -0.20 on 11/13/24 | ||
| Latest Earnings Date | 11/13/24 | 11/14/24 | 11/13/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||